BioSpace News Archive

IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“ IntelGenx ” or the “ Corporation ”) today announced that it intends to issue shares of common stock (“ Common Shares ”) of the Corporation in payment of the outstanding $7,577,000 aggregate principal amount of the Corporation’s 8.00% convertible unsecured subordinated debentures due June 30, 2020 (the “ Debentures ”). Under the terms of the trust indenture governing the Debentures

Delivering on a commitment the company made in April, CVS Health will open additional COVID-19 test sites at select CVS Pharmacy drive-thru locations on Friday, May 29 to establish a total of 1,000 sites across more than 30 states and Washington, DC.

scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, chief executive officer, will present at the following investor conferences in June: Jefferies Virtual Healthcare Conference Presentation: Thurs

Athira Pharma, Inc., a clinical-stage company dedicated to developing innovative first-in-class regenerative therapies with a lead drug candidate entering Phase 2/3 clinical trials this year for Alzheimer’s disease, today announced that Dr. Leen Kawas, President and Chief Executive Officer, will present at the Jefferies Virtual Global Healthcare Conferenc

Dr. Thao Truong Pascual has assumed the clinical leadership role for DaVita’s growing nephrology practice management arm

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that its management team will present and conduct one-on-one meetings virtually at the Jefferies Global Healthcare Conference 2020 and BMO 2020 Prescriptions for Success Healthcare Conference. Details are as follows: Conference: Jefferies Global Healthcare

BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three months ended March 31, 2020. Key highlights include: First quarter (Q1) 2020 Net Revenues of $6,062,846 increased by 35% versus Q1 2019 Q1 2020 Canadian Pharmaceutical Net Revenues of $5,955,561 increased by 39% versus Q1 2019 Q1 2020 EBITDA 1 of $1,997,987 increased by 66% versus Q1 2019 Q1 2020 Net Income After Taxes (NIAT)

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, announces it has entered into a sponsored research agreement with The University of Texas MD Anderson Cancer Center re

ViewRay, Inc. announced that the Company will present at the Jefferies 2020 Virtual Healthcare Conference.

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the formation of a Commercial Advisory Board consisting of leading experts in public health policy, epidemiology, and vaccine development. The Commercial Advisory Board will work closely with VBI’s management team on pre-commercialization and comm